Current advances in lipid and polymeric antimicrobial peptide delivery systems and coatings for the prevention and treatment of bacterial infections

Research output: Contribution to journalReviewResearchpeer-review

Documents

  • Fulltext

    Final published version, 2.67 MB, PDF document

  • Miriam E. van Gent
  • Muhanad Ali
  • Peter H. Nibbering
  • Sylvia N. Kłodzińska

Bacterial infections constitute a threat to public health as antibiotics are becoming less effective due to the emergence of antimicrobial resistant strains and biofilm and persister formation. Antimicrobial peptides (AMPs) are considered excellent alternatives to antibiotics; however, they suffer from limitations related to their peptidic nature and possible toxicity. The present review critically evaluates the chemical characteristics and antibacterial effects of lipid and polymeric AMP delivery systems and coatings that offer the promise of enhancing the efficacy of AMPs, reducing their limitations and prolonging their half-life. Unfortunately, the antibacterial activities of these systems and coatings have mainly been evaluated in vitro against planktonic bacteria in less biologically relevant conditions, with only some studies focusing on the antibiofilm activities of the formulated AMPs and on the antibacterial effects in animal models. Further improvements of lipid and polymeric AMP delivery systems and coatings may involve the functionalization of these systems to better target the infections and an analysis of the antibacterial activities in biologically relevant environments. Based on the available data we proposed which polymeric AMP delivery system or coatings could be profitable for the treatment of the different hard-to-treat infections, such as bloodstream infections and catheter-or implant-related infections.

Original languageEnglish
Article number1840
JournalPharmaceutics
Volume13
Issue number11
Number of pages39
ISSN1999-4923
DOIs
Publication statusPublished - 2021

Bibliographical note

Funding Information:
Funding: Miriam E. van Gent, Muhanad Ali and Peter H. Nibbering received funding from the Dutch Research Council (NWO), Novel Antibacterial Compounds and Therapies Antagonizing Resistance Program: grant number 16434, and Sylvia N. Klodzinska received funding from the Novo Nordisk Foundation, Grand Challenge Program: NNF16OC0021948.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

    Research areas

  • Antimicrobial coating, Antimicrobial peptide, Bacteria, Biofilm, Drug delivery system, Liposome, Nanogel, PLGA nanoparticle, Release profile

ID: 286421928